Q32 Bio Inc. (QTTB) Net Margin (2018 - 2023)

Q32 Bio has reported Net Margin for 6 years, with the latest figure at 1957.52% in Q4 2023.

• On a quarterly basis, Net Margin rose 189049.0% year-over-year to 1957.52% in Q4 2023; TTM through Sep 2024 was 508.95%, a 116182.0% increase from a year earlier, with the FY2025 full-year figure at 0.06%, changed N/A from the prior year.
• Net Margin was 1957.52% for Q4 2023 at Q32 Bio, down from 754.76% in the prior quarter.
• The five-year high for Net Margin was 11553.99% in Q1 2022, with the low at 8834.07% in Q1 2019.
• Average Net Margin over 5 years is 2727.91%, with a median of 3261.72% recorded in 2020.
• The sharpest annual moves came in 2022 and 2023: Net Margin soared 1155765 bps in 2022, then tumbled 1178602 bps in 2023.
• Over 5 years, Net Margin stood at 4292.54% in 2019, then increased by 29 bps to 3039.9% in 2020, then surged by 45 bps to 1679.8% in 2021, then slumped by 129 bps to 3848.0% in 2022, then jumped by 49 bps to 1957.52% in 2023.
• The last three Net Margin figures came in at 1957.52% (Q4 2023), 754.76% (Q3 2023), and 181.19% (Q2 2023), per Business Quant data.